December 14, 2006 - Company Release
Cerexa to be Acquired by Forest Laboratories for $480 Million Plus Potential $100 Million Milestone Payment

November 6, 2006 - Company Release
Cerexa to Present at Rodman & Renshaw Healthcare Conference

November 1, 2006 - Company Release
Cerexa Expands Portfolio of Novel Anti-Infective Therapies Through In-Licensing Agreement with Meiji Seika Kaisha

October 16, 2006 - Company Release
Cerexa to Present at BIO InvestorForum 2006

September 29, 2006 - Company Release
Phase 2 Study Shows Ceftaroline Highly Efficacious in Treatment of cSSSI Compared to Standard Therapy

September 9, 2006 - Company Release
Cerexa to Present at Credit Suisse Biotechnology Conference

August 2, 2006 - Company Release
Cerexa Reports Positive Top-Line Results for Phase 2 Clinical Trial of Ceftaroline

April 5, 2006 - Company Release
Cerexa Announces Completion of Enrollment in Ceftaroline Phase 2 Trial

March 28, 2006 - Company Release
Cerexa to Present at Future Leaders Conference

March 14, 2006 - Company Release
FDA Grants Cerexa Fast Track Designation for PPI-0903